NASDAQ$CYPH

Cypherpunk Technologies Inc · Q4 2024 earnings

Q4 2024 earnings · · Before market open · Investor relations

Briefing

Cypherpunk Technologies reported Q4 2024 a net loss of $67.6M.

For Q4 2024, Cypherpunk Technologies reported net loss was $67.6M. Management discusses segment trends, liquidity, and outlook in the quarterly filing.

  • Net loss $67.6M.
  • MD&A highlights operating priorities, liquidity, and sector risks.
  • MD&A highlights operating priorities, liquidity, and sector risks.

Headline financials

Total Revenue

$0.00

Previous: $634K-100.0%
EPS (adj)

-$0.37

Previous: -$0.46+19.6%
R&D Expenses

$13.1M

Previous: $11.7M+12.2%
G&A Expenses

$3.01M

Previous: $3.14M-3.9%
Net Income

-$67.6M

Previous: -$81.4M+17.0%
Operating Income

-$16.1M

Previous: -$14.8M-8.8%

Revenue & EPS history

Leap Therapeutics · Revenue · Quarterly

$0

Q4 2024-100%vs Q4 2023
Beat estimate in 2 of 3 quarters(67%)
ActualEstimate

Forward guidance

Outlook emphasizes clinical milestones, liquidity runway, and operating expense discipline.

Tailwinds

  • Pipeline progress and partnership economics.
  • Cash supports near-term operating plans.

Headwinds

  • Operating losses until commercial scale.
  • Financing and trial outcomes affect funding costs.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q4 2024

Historical avgQ4 2024

+11.8%

Avg return

Earnings day

+13.6%

Avg return

5 days after

+11.4%

Avg return

30 days after

50%

17 / 34 earnings

Positive

+389.9%

Q3 2025

Best reaction

-44.0%

Q3 2019

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q3 2025+389.9%+454.8%+228.8%
Q2 2025-28.3%-15.6%-11.8%
Q1 2025-2.5%-12.4%-0.5%
Q4 2024+16.9%-21.4%+3.1%
Q3 2024-11.1%-14.5%-9.2%
Q1 2024-1.1%-5.4%-22.1%
Q4 2023-0.5%+14.0%+35.7%
Q3 2023+13.0%+32.6%+128.3%
Q2 2023+7.6%-8.9%-28.4%
Q1 2023+17.1%+44.4%+44.4%
Q4 2022-12.1%-0.9%+11.5%
Q3 2022+12.0%-3.2%-17.7%
Q2 2022+10.0%-0.8%+30.0%
Q1 2022+34.6%+25.4%+10.0%
Q4 2021-8.6%+2.3%+0.0%
Q3 2021+0.4%+0.8%+2.9%
Q2 2021+0.6%+3.6%-12.0%
Q1 2021+9.5%+8.8%+21.6%
Q4 2020+7.9%+6.1%-21.1%
Q3 2020+0.6%-3.1%+21.4%
Q2 2020-3.1%+0.3%-5.6%
Q1 2020+0.0%+0.4%+3.1%
Q4 2019-4.1%-14.2%+20.3%
Q3 2019-44.0%-33.7%-29.7%
Q2 2019-8.9%-10.2%+2.5%
Q1 2019-1.6%-6.5%-0.6%
Q4 2018+10.7%+4.3%-9.1%
Q3 2018-8.8%-17.1%-26.8%
Q2 2018+2.1%+6.1%+8.7%
Q4 2017-1.4%+1.2%+30.8%
Q3 2017-2.1%+16.9%+9.2%
Q2 2017-5.6%+2.0%-6.2%
Q1 2017+8.6%+10.4%-8.9%
Q4 2016+4.0%-4.7%-16.2%
Q3 2016
Q2 2016
Q1 2016
Q4 2015
Q3 2015
Q2 2015
Q1 2015
Q4 2014
Q3 2014
Q2 2014
Q1 2014
Q4 2013
Q3 2013
Q2 2013
Q1 2013

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro